Validation of Medication Non-adherence Model (UK)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02115412

Enrollment

750

Registered

2014-04-16

Start date

2014-07-31

Completion date

2015-12-31

Last updated

2020-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Illness, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, Medication Management at Home, Primary Care

Brief summary

Research has shown that nearly 50% of patients with chronic conditions around the globe do not adhere to their prescribed medicine, leading to enormous cost to the healthcare providers. Non-adherence can be due to various forms and have multiple causes. To address this need, Philips Research has developed Medication Non-adherence model. This tool will help in developing a systemic way of assessing medication non-adherence and providing decision support for targeted intervention to healthcare professionals. The aim of this study is to validate this model with 750 chronically ill patients in UK.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 89 Years

Healthy volunteers

Inclusion criteria

* Patients with chronic disease between 18 -89 years old. * Chronic medication use (\> 3 medications; excluding analgesic, ointment and eye drop medication) * Patients registered with a given Pharmacy at least 1 year before entering into the study.

Exclusion criteria

* Patients who are illiterate in English. * Patients who are unable to give consent to the study. * Enrolled in another clinical trial, which requires change in their routinely medication. * Patients currently using automatic medication reminder services (excluding the pharmacy service). * Patients with dementia or any other mental conditions, that might affects the accuracy of the answers provided.

Design outcomes

Primary

Measure	Time frame	Description
Adherence determinants	6 months	Self-reported behavioral questionnaire completed at 3 monthly intervals

Secondary

Measure	Time frame	Description
Medication usage	18 months	Collecting refill data from the pharmacy where patients are registered to. Time Frame: 18 months (12 month prior to enrollment + 6 months during the study

Other

Measure	Time frame	Description
Adverse Events	18 months	Any adverse events (eg: hospitalisation, elective surgeries), which may have resulted change in their daily medication routine Time Frame: 18 months, meaning 12 month prior to enrollment + 6 months during the study

Countries

United Kingdom

Outcome results